Trans folks: Perrigo updated the FDA drug shortage database today, and have release plans in October and November for 20 and 40 mg/mL doses.
If they changed manufacturers, process, or components, then there are regulatory hurdles, but that has nothing to do with the drug
-
-
But the drug is already approved and the shortage reason listed is "Inactive Ingredient Shortage". This doesn't require reapproval
-
The manufacturer, Luitpold, was approved in 2010, so that's not a barrier either.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.